Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKesson
Farmers Insurance
McKinsey
Medtronic
Teva
Cerilliant
Harvard Business School
Cantor Fitzgerald

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019501

« Back to Dashboard

NDA 019501 describes ROGAINE (FOR WOMEN), which is a drug marketed by Johnson And Johnson and is included in one NDA. It is available from one supplier. Additional details are available on the ROGAINE (FOR WOMEN) profile page.

The generic ingredient in ROGAINE (FOR WOMEN) is minoxidil. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Summary for 019501
Tradename:ROGAINE (FOR WOMEN)
Applicant:Johnson And Johnson
Ingredient:minoxidil
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019501
Suppliers and Packaging for NDA: 019501
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROGAINE (FOR MEN) minoxidil SOLUTION;TOPICAL 019501 NDA Johnson & Johnson Consumer Inc. 42002-105 42002-105-02 1 BOTTLE, PLASTIC in 1 CARTON (42002-105-02) > 60 mL in 1 BOTTLE, PLASTIC
ROGAINE (FOR MEN) minoxidil SOLUTION;TOPICAL 019501 NDA Johnson & Johnson Consumer Inc. 42002-105 42002-105-06 3 BOTTLE, PLASTIC in 1 CARTON (42002-105-06) > 60 mL in 1 BOTTLE, PLASTIC

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength2%
Approval Date:Feb 9, 1996TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength2%
Approval Date:Feb 9, 1996TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Teva
Daiichi Sankyo
Chubb
McKinsey
Medtronic
Fuji
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.